The diagnosis value of endobronchial ultrasound transbronchial lung biopsy combined with rapid on‐site evaluation in peripheral lung cancer
| Autor: | Qian Zhang, Ji Wang Wang, Chuan Zhen Chi, Qi Yuan, Chunhua Xu, Wei Wang, Xiu Wei Zhang, Yuchao Wang |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Image-Guided Biopsy Male Pulmonary and Respiratory Medicine China medicine.medical_specialty Lung Neoplasms Time Factors Site evaluation Endosonography 03 medical and health sciences 0302 clinical medicine Bronchoscopy Biopsy medicine Humans Immunology and Allergy Prospective Studies 030212 general & internal medicine Endobronchial ultrasound Lung cancer Lung Genetics (clinical) Aged Peripheral lung cancer medicine.diagnostic_test business.industry Transbronchial lung biopsy Middle Aged medicine.disease 030228 respiratory system Female Radiology Tomography X-Ray Computed business Complication |
| Zdroj: | The Clinical Respiratory Journal. 14:447-452 |
| ISSN: | 1752-699X 1752-6981 |
| DOI: | 10.1111/crj.13151 |
| Popis: | INTRODUCTION Rapid on-site evaluation (ROSE) has the potential to increase endobronchial ultrasound transbronchial lung biopsy with guide sheath (EBUS-GS-TBLB) accuracy in the diagnosis of peripheral lung cancer. However, studies have reported controversial results. OBJECTIVES The aim of the study was to evaluate the diagnosis value of EBUS-GS-TBLB combination with ROSE in peripheral lung cancer. METHODS A total of 138 patients undergoing EBUS-GS-TBLB and ultimately diagnosed with lung cancer were allocated into the ROSE group and non-ROSE group. The result of the diagnostic yields, number of biopsy sites, the complication, cytopathological diagnostic cost and procedure times of EBUS-GS-TBLB with ROSE and without ROSE were compared. RESULTS The diagnostic yields of TBLB were 87.8% and 78.1% in ROSE group and non-ROSE group, respectively (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |